1. Artemzhongdianolides A1-A21, antihepatic fibrosis guaiane-type sesquiterpenoid dimers from Artemisia zhongdianensis.
- Author
-
Dong, Wei, Li, Tian-Ze, Huang, Xiao-Yan, He, Xiao-Feng, Geng, Chang-An, Zhang, Xue-Mei, and Chen, Ji-Jun
- Subjects
- *
DIMERS , *ARTEMISIA , *FIBROSIS , *LIVER cells , *HYALURONIC acid , *COLLAGEN - Abstract
[Display omitted] • Twenty-one new guaianolide dimers were isolated from Artemisia zhongdianensis. • Nine compounds exhibited cytotoxicity against HSC-LX2. • Compounds 2, 6 and 13 displayed inhibitory activity on the deposition of Col Ⅰ, HA and HL. • This study provides more evidence for understanding of antihepatic fibrosis potency of Artemisia zhongdianensis. In the search for new antihepatic fibrosis candidates, it was observed that the EtOH extract of Artemisia zhongdianensis and EtOAc fraction had cytotoxicity against hepatic stellate cell line LX2 (HSC-LX2) with the inhibitory ratios of 85.7 % and 83.9 % at 400 μg/mL. 21 new guaianolide dimers, artemzhongdianolides A1 − A21 (1 – 21) were isolated from the active fractions under the guidance of bioassay, and elucidated by spectral analyses (HRESIMS, 1D and 2D NMR, IR, ECD). The absolute stereochemistry of compounds 1 , 13 , and 14 was determined by single-crystal X-ray diffraction analyses. Cytotoxicity evaluation suggested that nine compounds exhibited activity against HSC-LX2 with IC 50 values ranging from 14.0 to 95.2 μM. Of them, compounds 2 , 6 , and 13 displayed significant cytotoxicity against HSC-LX2 with IC 50 values of 22.1, 24.3 and 14.0 μM, which were 6 to 10 times more active than the positive drug silybin (IC 50 , 148.6 μM). Preliminary mechanism study revealed that compounds 2 , 6 , and 13 could markedly inhibited the deposition of human collagen type Ⅰ (Col Ⅰ), human hyaluronic acid (HA), and human laminin (HL) with IC 50 values of 37.9, 54.8, and 28.0 μM (Col Ⅰ), 29.5, 25.3, and 42.9 μM (HL), 31.2, 94.6, and 12.4 μM (HA), which were 1.5 to 13-fold more potent than silybin. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF